Status: Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
The main purpose of study is to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of benralizumab.
Participants needed: 14
Trial details
Phase: Phase 3Age: 6-17Biological sex: AllType: InterventionalSponsor: AstraZenecaUpdated: Jun 30, 2026Locations: 15
Eligibility criteria
Male or female participants must be aged 6 to < 18 years of age at the time of s... [+7]
Any current malignancy or history of malignancy. [+9]